Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04661683 · ClinicalTrials.gov registry record · NA

Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol

A NA study of Vaping and Vascular Stiffness, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04661683: Recruiting NA study of Vaping and Vascular Stiffness, sponsored by University of California, Los Angeles.

NCT04661683 is a NA study of Vaping and Vascular Stiffness that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 12 participants, below the 760-participant average among 18 other Vaping trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04661683, a NA study of Vaping and Vascular Stiffness, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

In the United States, secondhand smoke is the third leading preventable cause of death. Flavored hookah (waterpipe) tobacco smoking, a highly social activity common in hookah bars, is a key source of SHS exposure. While smoke-free air laws have decreased exposure to secondhand smoke, the majority of laws do not include hookah smoking. Thus, as a social outlet for youth and young adults, hookah smoke exposure may harm non-smokers, including women of reproductive age or pregnant, hookah bar workers, children, and individuals with heart and lung disease. While more is known on the acute effects of active hookah smoking and the literature is emerging on active e-hookah vaping, little is known about the acute vascular effects of secondhand exposure to hookah smoke and aerosol. The study aims to examine the acute effects of secondhand exposure of hookah smoke and aerosol on endothelial and vascular function. Eligible volunteers will be invited to participate in a total of 3 study visits (2-3 hours each): e-hookah aerosol exposure, charcoal-heated hookah smoke exposure and smoke-free room air. Non-invasive blood pressure and blood flow measurements will be taken before and after the exposure sessions.

Primary Outcome

Using ultrasound, FMD of the brachial artery induced by reactive hyperemia, will be used to measure endothelium-dependent vasodilator function. Baseline diameter and velocity will be recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain true peak vasodilatory response.

Interventions

  • OTHER Combustible Hookah Smoke
  • OTHER Electronic Hookah Aerosol
  • OTHER Clean Room Air

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-06-25
Est. Completion 2027-04-15
Phase NA

What NCT04661683 shows while recruiting

NCT04661683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 760-participant average among 18 other Vaping trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Vaping appearing as the primary indexed condition, and to 3 interventions - of which Combustible Hookah Smoke is the first listed.

NCT04661683 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04661683 about?

NCT04661683 is a clinical study titled "Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol". In the United States, secondhand smoke is the third leading preventable cause of death. Flavored hookah (waterpipe) tobacco smoking, a highly social activity common in hookah bars, is a key source of SHS exposure. While smoke-free air laws have decreased exposure to secondhand smoke, the majority of...

What is the current status of trial NCT04661683?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2021-06-25. Estimated completion is 2027-04-15.

What conditions does trial NCT04661683 study?

This clinical trial studies the following conditions: Vaping, Vascular Stiffness, Hookah Smoking, Secondhand Aerosol.

What interventions are being tested in trial NCT04661683?

The interventions under investigation include: Combustible Hookah Smoke (OTHER), Electronic Hookah Aerosol (OTHER), Clean Room Air (OTHER).

Who is sponsoring clinical trial NCT04661683?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04661683 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaping

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04661683's enrollment target sits among peer trials

12 19th of 18 the lowest of 18 other Vaping trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04661683, the US trial registry maintained by the National Library of Medicine. NCT04661683 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.